Cynthia Veenstra
Linkoeping, E, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction to: Age-stratified Assessment of Brain Volumetric Segmentation on the Indian Population Using Quantitative Magnetic Resonance Imaging.
Journal: Clinical neuroradiology
Published: May 15, 2024
Age-stratified Assessment of Brain Volumetric Segmentation on the Indian Population Using Quantitative Magnetic Resonance Imaging.
Journal: Clinical neuroradiology
Published: May 06, 2023
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery: a long-term follow-up of the SweBCG91-RT randomised trial.
Journal: Molecular oncology
Published: June 02, 2020
The effects of PTPN2 loss on cell signalling and clinical outcome in relation to breast cancer subtype.
Journal: Journal of cancer research and clinical oncology
Published: March 19, 2019
PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer.
PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: November 08, 2018
ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab.
Journal: Oncology letters
Published: September 19, 2018
Met and its ligand HGF are associated with clinical outcome in breast cancer.
Journal: Oncotarget
Published: February 24, 2016
Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.
Journal: Breast cancer research and treatment
Published: April 27, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026